Humoral Immunity Study After Booster Vaccination of " Soberana Plus " (The Republic of Cuba) Against COVID-19
Condition: Humoral Immunity Intervention: Biological: Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. Sponsor: Gomel State Medical University Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials